Metraipolis › archive › dc_248029670cd1

Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights — Europe PMC PMID:42634207

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42634207
DOI
10.1111/jcmm.71328
License (as archived)
solo-consultazione
Archived
2026-10-17T06:21:20.423Z
SHA-256 of the archived text
c8405c1307c83dac18f78c6ad4b10c5a19508261394cf1fd1d58f4a9c40fb3c8
Stable URL of this page
https://metraipolis.com/documento/dc_248029670cd1

How to cite

Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights — Europe PMC PMID:42634207 — Europe PMC (en), https://europepmc.org/article/MED/42634207 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_248029670cd1 (Metraipolis archive dc_248029670cd1, sha256 c8405c1307c83dac18f78c6ad4b10c5a19508261394cf1fd1d58f4a9c40fb3c8)
BibTeX
@misc{dc248029670cd1,
  title = {Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights — Europe PMC PMID:42634207},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42634207},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_248029670cd1; sha256 c8405c1307c83dac18f78c6ad4b10c5a19508261394cf1fd1d58f4a9c40fb3c8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42634207. Agents can read the archived copy with the MCP tool read_document.